Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Immucell reports preliminary Q2 revenue $3.9M vs. $4.5M last year » 06:35
07/07/22
07/07
06:35
07/07/22
06:35
ICCC

Immucell

$8.28 /

-0.22 (-2.59%)

"A material…

"A material disruption in the supply to us of needed plastic parts limited our production and sales during the quarter," commented Michael Brigham, President and CEO of ImmuCell. "We had a backlog of orders worth approximately $704,000 as of June 30, 2022 that all could have been shipped to customers erasing this drop in sales for the quarter, if not for this supply disruption that we are working to resolve during the third quarter. The strategic investments we are making to incrementally expand our First Defense manufacturing capacity further to approximately $30 million per year during the third quarter and to approximately $35 million per year during the fourth quarter are on track. Our work to achieve regulatory approval to commercialize Re-Tain continues. We expect a response from the FDA during the third quarter to our submission of the final Technical Section required to complete our New Animal Drug Application, and we have submitted our responses to all of the findings from a recent pre-approval inspection by the FDA."

ShowHide Related Items >><<
ICCC Immucell
$8.28 /

-0.22 (-2.59%)

ICCC Immucell
$8.28 /

-0.22 (-2.59%)

Over a quarter ago
On The Fly
Fly Intel: After-Hours Movers » 18:01
04/11/22
04/11
18:01
04/11/22
18:01
TSRI

TSR

$11.51 /

-2.01 (-14.87%)

, BDSX

Biodesix

$1.60 /

-0.08 (-4.76%)

, ICCC

Immucell

$8.93 /

-0.67 (-6.98%)

, XMTR

Xometry

$34.61 /

-0.93 (-2.62%)

, UIHC

United Insurance

$3.01 /

+0.04 (+1.35%)

, ICLR

Icon

$247.76 /

-13.655 (-5.22%)

, AEI

Alset EHome

/

+

, HOTH

Hoth Therapeutics

$1.04 /

+0.4276 (+69.82%)

, EDSA

Edesa Biotech

$2.81 /

+0.105 (+3.88%)

, QSR

Restaurant Brands

$59.29 /

+0.14 (+0.24%)

, DNUT

Krispy Kreme

$13.59 /

-0.2 (-1.45%)

, SBUX

Starbucks

$80.67 /

-0.765 (-0.94%)

Check out this evening's…

ShowHide Related Items >><<
XMTR Xometry
$34.61 /

-0.93 (-2.62%)

UIHC United Insurance
$3.01 /

+0.04 (+1.35%)

SBUX Starbucks
$80.67 /

-0.765 (-0.94%)

QSR Restaurant Brands
$59.29 /

+0.14 (+0.24%)

ICLR Icon
$247.76 /

-13.655 (-5.22%)

HOTH Hoth Therapeutics
$1.04 /

+0.4276 (+69.82%)

EDSA Edesa Biotech
$2.81 /

+0.105 (+3.88%)

DNUT Krispy Kreme
$13.59 /

-0.2 (-1.45%)

BDSX Biodesix
$1.60 /

-0.08 (-4.76%)

AEI Alset EHome
/

+

TSRI TSR
$11.51 /

-2.01 (-14.87%)

BDSX Biodesix
$1.60 /

-0.08 (-4.76%)

03/15/22 Canaccord
Biodesix price target lowered to $10 from $18 at Canaccord
02/15/22 Canaccord
Biodesix price target lowered to $18 from $22 at Canaccord
11/17/21 Morgan Stanley
Biodesix downgraded to Equal Weight from Overweight at Morgan Stanley
11/16/21 Canaccord
Biodesix price target lowered to $22 from $24 at Canaccord
ICCC Immucell
$8.93 /

-0.67 (-6.98%)

XMTR Xometry
$34.61 /

-0.93 (-2.62%)

04/11/22 Loop Capital
Loop Capital starts Xometry at Buy, expects 'significant' growth to continue
04/11/22 Loop Capital
Xometry initiated with a Buy at Loop Capital
01/06/22 Goldman Sachs
Xometry assumed with a Buy at Goldman Sachs
12/09/21 RBC Capital
Xometry price target raised to $58 from $53 at RBC Capital
UIHC United Insurance
$3.01 /

+0.04 (+1.35%)

08/10/21 Raymond James
United Insurance downgraded to Market Perform from Outperform at Raymond James
08/10/21 Raymond James
United Insurance downgraded to Market Perform from Outperform at Raymond James
ICLR Icon
$247.76 /

-13.655 (-5.22%)

04/11/22 Deutsche Bank
Icon upgraded to Buy from Hold at Deutsche Bank
03/07/22 Mizuho
Icon price target lowered to $272 from $315 at Mizuho
02/25/22 Deutsche Bank
Icon price target lowered to $235 from $287 at Deutsche Bank
02/23/22 Barclays
Icon price target lowered to $255 from $285 at Barclays
AEI Alset EHome
/

+

HOTH Hoth Therapeutics
$1.04 /

+0.4276 (+69.82%)

EDSA Edesa Biotech
$2.81 /

+0.105 (+3.88%)

12/20/21 H.C. Wainwright
Edesa Biotech initiated with a Buy at H.C. Wainwright
09/20/21 Brookline
Edesa Biotech's Covid-19 Phase 2 data is 'promising,' says Brookline
QSR Restaurant Brands
$59.29 /

+0.14 (+0.24%)

04/11/22 Citi
Restaurant Brands downgraded to Neutral from Buy at Citi
02/17/22 Deutsche Bank
Restaurant Brands price target lowered to $72 from $75 at Deutsche Bank
02/15/22 Stephens
Restaurant Brands price target raised to $65 from $62 at Stephens
01/14/22 Evercore ISI
Evercore ups Texas Roadhouse to Outperform on underappreciated recovery leverage
DNUT Krispy Kreme
$13.59 /

-0.2 (-1.45%)

04/11/22 Citi
Krispy Kreme downgraded to Neutral from Buy at Citi
01/11/22 BofA
Krispy Kreme initiated with a Buy at BofA
12/01/21
Fly Intel: Top five analyst downgrades
12/01/21 Goldman Sachs
Krispy Kreme downgraded to Sell from Neutral at Goldman Sachs
SBUX Starbucks
$80.67 /

-0.765 (-0.94%)

04/11/22 Citi
Starbucks downgraded to Neutral from Buy at Citi
04/06/22 Piper Sandler
Piper lists winners and losers from semi-annual teen survey
04/05/22 BMO Capital
Starbucks price target lowered to $115 from $125 at BMO Capital
04/05/22 Wedbush
Starbucks downgraded to Neutral from Outperform at Wedbush
XMTR Xometry
$34.61 /

-0.93 (-2.62%)

UIHC United Insurance
$3.01 /

+0.04 (+1.35%)

TSRI TSR
$11.51 /

-2.01 (-14.87%)

SBUX Starbucks
$80.67 /

-0.765 (-0.94%)

QSR Restaurant Brands
$59.29 /

+0.14 (+0.24%)

ICLR Icon
$247.76 /

-13.655 (-5.22%)

ICCC Immucell
$8.93 /

-0.67 (-6.98%)

EDSA Edesa Biotech
$2.81 /

+0.105 (+3.88%)

DNUT Krispy Kreme
$13.59 /

-0.2 (-1.45%)

BDSX Biodesix
$1.60 /

-0.08 (-4.76%)

  • 12
    Apr
  • 05
    Aug
  • 01
    Jul
  • 30
    Jun
  • 11
    May
SBUX Starbucks
$80.67 /

-0.765 (-0.94%)

QSR Restaurant Brands
$59.29 /

+0.14 (+0.24%)

TSRI TSR
$11.51 /

-2.01 (-14.87%)

SBUX Starbucks
$80.67 /

-0.765 (-0.94%)

QSR Restaurant Brands
$59.29 /

+0.14 (+0.24%)

EDSA Edesa Biotech
$2.81 /

+0.105 (+3.88%)

DNUT Krispy Kreme
$13.59 /

-0.2 (-1.45%)

SBUX Starbucks
$80.67 /

-0.765 (-0.94%)

QSR Restaurant Brands
$59.29 /

+0.14 (+0.24%)

DNUT Krispy Kreme
$13.59 /

-0.2 (-1.45%)

Earnings
Immucell reports preliminary Q1 revenue $6M vs. $4.1M last year » 16:09
04/11/22
04/11
16:09
04/11/22
16:09
ICCC

Immucell

$8.92 /

-0.68 (-7.08%)

"Sales during the…

"Sales during the first quarter ended March 31, 2022 increased by 46% to $6.0 million compared to the same period of the prior year, which is exciting for us," commented Michael Brigham, president and CEO of ImmuCell. "This favorable comparison does reflect tighter supply constraints during the first quarter of 2021 before the first level of investments to increase our production capacity had been completed."

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.